发明名称 GLUCAGON-LIKE PEPTIDE 1 (GLP-1)PHARMACEUTICAL FORMULATIONS
摘要 <p>A composition is disclosed comprising glucagon- like peptide 1 (GLP-I) particles in combination with diketopiperazine (DKP) that is stable both in vitro and in vivo. The composition has utility as a pharmaceutical formulation for treating diseases such as diabetes, cancers, and obesity but is not limited to such diseases or conditions. In particularly, the composition has utility as a pharmaceutical formulation for pulmonary delivery.</p>
申请公布号 KR20140072138(A) 申请公布日期 2014.06.12
申请号 KR20147011316 申请日期 2007.04.16
申请人 MANNKIND CORPORATION 发明人 GREENE STEPHANIE;BRANDT DAVID;GELBER COHAVA;KING MARK;CHEATHAM WAYMAN WENDELL;OBERG KEITH;LEONE BAY ANDREA;HOKENSON MARK J.;FARIS MARY
分类号 A61K38/26;A61K9/14;A61K9/16;A61K31/496 主分类号 A61K38/26
代理机构 代理人
主权项
地址